FocalTherics™ to Announce Third Quarter 2026 Financial Results on
Company to host conference call and webcast on
An accompanying conference call and webcast will be conducted by
Call Details:
| Date: | |
| Domestic: | 1-833-419-0865 |
| International: | 1-785-838-9333 |
| Passcode: | FOCAL |
| Webcast: | https://viavid.webcasts.com/starthere.jsp?ei=1776674&tp_key=37ee4700b1 |
About FocalTherics
A recognized leader in robotic focal therapy, FocalTherics develops, manufactures, and markets minimally invasive medical devices worldwide to treat various conditions using proprietary focused ultrasound technology. The Company’s flagship platform, Focal One® Robotic HIFU, combines advanced imaging, real-time treatment planning, robotic precision, and HIFU technology to deliver personalized focal therapy designed to optimize clinical outcomes while preserving quality of life.
Investor Contacts
Louisa Smith
Gilmartin Group
investor.relations@focalone.com
Source: FocalTherics (TM)
